Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study.

Stupp, Roger and Hegi, Monika E. and Gorlia, Thierry and Erridge, Sara and Grujicic, Danica and Steinbach, Joachim Peter and Wick, Wolfgang and Tarnawski, Rafal and Nam, Do-Hyun and Weyerbrock, Astrid and Hau, Peter and Taphoorn, Martin J. B. and Nabors, Louis B. and Reardon, David A. and Van den Bent, Martin J. and Perry, James R. and Hong, Yong Kil and Hicking, Christine and Picard, Martin and Weller, Michael (2013) Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study. JOURNAL OF CLINICAL ONCOLOGY, 31 (18supp): LBA2009. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Petra Gürster
Date Deposited: 16 Jun 2020 09:26
Last Modified: 16 Jun 2020 09:26
URI: https://pred.uni-regensburg.de/id/eprint/16499

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.